Topical Products for Inflammatory Skin Diseases

← Back to Class List

PDL Status Values

Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the Non-Preferred Drugs in Select PDL Classes prior authorization criteria. New drugs will be listed as N until reviewed by the P&T Committee and are subject to the New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.

To request a Prior Authorization, please use this form.

Generic Name Brand Name Form PDL
Current Drug Use Criteria New Drug Evaluation
pimecrolimus ELIDEL CREAM (G) Y PA Document  
pimecrolimus PIMECROLIMUS CREAM (G) Y PA Document  
tacrolimus PROTOPIC OINT. (G) Y PA Document  
tacrolimus TACROLIMUS OINT. (G) Y PA Document  
crisaborole EUCRISA OINT. (G) N PA Document May 25, 2017
ruxolitinib phosphate OPZELURA CREAM (G) N PA Document